Cargando…

Anti-inflammatory Effects of Siponimod in a Mouse Model of Excitotoxicity-Induced Retinal Injury

Glaucoma is a leading cause of permanent blindness worldwide and is characterized by neurodegeneration linked to progressive retinal ganglion cell (RGC) death, axonal damage, and neuroinflammation. Glutamate excitotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors plays a crucial role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basavarajappa, Devaraj, Gupta, Vivek, Chitranshi, Nitin, Viswanathan, Deepa, Gupta, Veer, Vander Wall, Roshana, Palanivel, Viswanthram, Mirzaei, Mehdi, You, Yuyi, Klistorner, Alexander, Graham, Stuart L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657799/ https://www.ncbi.nlm.nih.gov/pubmed/37542647 http://dx.doi.org/10.1007/s12035-023-03535-0

Ejemplares similares

Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma
por: Basavarajappa, Devaraj, et al.
Publicado: (2022)

Neuroprotective Effects of Neuropeptide Y on Human Neuroblastoma SH-SY5Y Cells in Glutamate Excitotoxicity and ER Stress Conditions
por: Palanivel, Viswanthram, et al.
Publicado: (2022)

Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin
por: Gupta, Vivek, et al.
Publicado: (2017)

Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networks
por: Mirzaei, Mehdi, et al.
Publicado: (2022)

Molecular determinants and interaction data of cyclic peptide inhibitor with the extracellular domain of TrkB receptor
por: Chitranshi, Nitin, et al.
Publicado: (2016)

Correction to: Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022)

Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
por: Sharma, Samridhi, et al.
Publicado: (2022)

Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates
por: Chitranshi, Nitin, et al.
Publicado: (2020)

Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease
por: Godinez, Angela, et al.
Publicado: (2022)

Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer’s disease: a meta-analysis
por: Sheriff, Samran, et al.
Publicado: (2023)

Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
por: Abbasi, Mojdeh, et al.
Publicado: (2021)

Cell Cycle Deficits in Neurodegenerative Disorders: Uncovering Molecular Mechanisms to Drive Innovative Therapeutic Development
por: Joseph, Chitra, et al.
Publicado: (2020)

Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief Review
por: Abbasi, Mojdeh, et al.
Publicado: (2018)

Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes
por: Mirzaei, Mehdi, et al.
Publicado: (2017)

Evaluating associations of RNFL thickness and multifocal VEP with cognitive assessment and brain MRI volumes in older adults: Optic nerve decline and cognitive change (ONDCC) initiative
por: Shen, Ting, et al.
Publicado: (2022)

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
por: Chitranshi, Nitin, et al.
Publicado: (2021)

Oxidative Stress Induced Dysfunction of Protein Synthesis in 661W Mice Photoreceptor Cells
por: Deng, Liting, et al.
Publicado: (2023)

TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
por: Gupta, Vivek K., et al.
Publicado: (2013)

BDNF Polymorphism: A Review of Its Diagnostic and Clinical Relevance in Neurodegenerative Disorders
por: Shen, Ting, et al.
Publicado: (2018)

Complement pathway in Alzheimer’s pathology and retinal neurodegenerative disorders – the road ahead
por: Mirzaei, Mehdi, et al.
Publicado: (2019)

Glaucoma Pathogenesis and Neurotrophins: Focus on the Molecular and Genetic Basis for Therapeutic Prospects
por: Chitranshi, Nitin, et al.
Publicado: (2018)

Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells
por: Deng, Liting, et al.
Publicado: (2019)

Anterograde Degeneration along the Visual Pathway after Optic Nerve Injury
por: You, Yuyi, et al.
Publicado: (2012)

Siponimod for multiple sclerosis
Publicado: (2021)

Association Between BDNF Val66Met Polymorphism and Optic Neuritis Damage in Neuromyelitis Optica Spectrum Disorder
por: Shen, Ting, et al.
Publicado: (2019)

Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease
por: Abyadeh, Morteza, et al.
Publicado: (2021)

Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins
por: Chitranshi, Nitin, et al.
Publicado: (2015)

Key Genes and Biochemical Networks in Various Brain Regions Affected in Alzheimer’s Disease
por: Abyadeh, Morteza, et al.
Publicado: (2022)

A Proteomic View of Cellular and Molecular Effects of Cannabis
por: Abyadeh, Morteza, et al.
Publicado: (2021)

Siponimod ameliorates experimental autoimmune neuritis
por: Uchi, Takafumi, et al.
Publicado: (2023)

Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
por: Abyadeh, Morteza, et al.
Publicado: (2023)

Prospects of siponimod in secondary progressive multiple sclerosis
por: McGinley, Marisa, et al.
Publicado: (2018)

Abnormalities in Glutamate Metabolism and Excitotoxicity in the Retinal Diseases
por: Ishikawa, Makoto
Publicado: (2013)

Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
por: Behrangi, Newshan, et al.
Publicado: (2019)

Siponimod: A Review in Secondary Progressive Multiple Sclerosis
por: Scott, Lesley J.
Publicado: (2020)

The Association of APOE ε4 Allele with Retinal Layer Thickness and Microvasculature in Older Adults: Optic Nerve Decline and Cognitive Change Study
por: Sheriff, Samran, et al.
Publicado: (2023)

Does Siponimod Exert Direct Effects in the Central Nervous System?
por: Kipp, Markus
Publicado: (2020)

Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis
por: Scott, Lesley J.
Publicado: (2021)

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2020)

Migraine, interferon β1a and siponimod immunomodulator therapies
por: Dahaba, Ashraf A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ir05nfdpecjcoi49eped1qbdr